Literature DB >> 32996711

The impact of structural optical coherence tomography changes on visual function in retinal vein occlusion.

Martin Michl1, Xuhui Liu1,2, Alexandra Kaider3, Amir Sadeghipour1, Bianca S Gerendas1, Ursula Schmidt-Erfurth1.   

Abstract

PURPOSE: We aimed to determine the correlation between optical coherence tomography (OCT)- and demographic features and baseline best corrected visual acuity (BCVA) in treatment-naïve patients with retinal vein occlusion (RVO).
METHODS: This was a cross-sectional posthoc analysis of OCT images that included RVO patients from two prospective, open-label, multicentre studies. The morphological grading was done manually, in the standardized setting of a reading centre. Main outcome measure was the estimated difference in Early Treatment Diabetic Retinopathy Study letters associated with each individual biomarker.
RESULTS: Included were 381/301 treatment-naïve patients with BRVO/CRVO. For BRVO, statistically significant correlations with BCVA were seen for a 100 µm increase in central subfield thickness (CST; -3.1 letters), intraretinal cysts at centre point (CP; +4.1), subretinal fluid (SRF) at CP (+3.0) and hyperreflective foci (HRF) at the central B-scan (-2.2). In CRVO, a 100 µm increase in CST was associated with a loss of -3.4 letters. In the total cohort, 100 µm increase in CST, SRF at CP and HRF at the central B-scan correlated with a difference of -3.2,+3.2 and -2.0 letters. A 10-year increase in age and female gender yielded a -2.0 and -2.5 letter decrease in the total cohort. Adjusted multiple R2 for the respective group was 18.3%/26.3%/23.5%.
CONCLUSIONS: Of all parameters studied, only CST and age were consistently associated with worse BCVA in treatment-naïve RVO patients. Morphology on OCT explained only a modest part of functional loss in this patient cohort.
© 2020 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Keywords:  biomarker; function; morphology; optical coherence tomography; retinal vein occlusion

Year:  2020        PMID: 32996711     DOI: 10.1111/aos.14621

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  3 in total

Review 1.  [Biomarkers in the treatment of retinal vein occlusion].

Authors:  Jakob Siedlecki; Lars-Olof Hattenbach; Nikolas Feltgen; Siegfried G Priglinger
Journal:  Ophthalmologie       Date:  2022-10-06

2.  Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study.

Authors:  Haiying Zhou; Zuhua Sun; Meng Zhao; Xiaoling Liu; Xuan Jiao; Weiwei Zheng; Feng Zhang
Journal:  Comput Math Methods Med       Date:  2022-07-29       Impact factor: 2.809

Review 3.  Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications.

Authors:  Serena Fragiotta; Solmaz Abdolrahimzadeh; Rosa Dolz-Marco; Yoichi Sakurada; Orly Gal-Or; Gianluca Scuderi
Journal:  J Ophthalmol       Date:  2021-12-17       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.